Combined Endoscopic Sinus Surgery and Rhinosinus Surgery for Obstructive Nasal Syndromes
Authors/Creators
- 1. M.B.Ch.B., F.I.C.M.S. \ (ENT), Specialist in Otolaryngology, Iraqi Ministry of Health, Al-Karkh Health Directorate, Abu-Ghraib General Hospital, Baghdad, Iraq.
- 2. M.B.Ch.B., F.I.B.M.S. \ (ENT), Specialist in Otolaryngology, Iraqi Ministry of Health, Al-Karkh Health Directorate, Abu-Ghraib General Hospital, Baghdad, Iraq.
- 3. M.B.Ch.B., F.I.B.M.S. \ (ENT), Specialist in Otolaryngology, Iraqi Ministry of Health, Al-Karkh Health Directorate, Pediatric Central Teaching Hospital, Baghdad, Iraq.
Description
Background: The clinical symptoms and treatment outcomes of chronic sinusitis are influenced by environmental factors, limited access to health care services, and it is a significant health burden in Iraq. The main goal of this research was to assess the efficacy of FESS and assistive procedures in the nose. A prospective observational study was performed from January 2025 to January 2026, in two specialized ENT centers in Iraq, where 134 patients with drug-resistant chronic sinusitis were included. Our primary outcome measures included the SNOT-22 score, the nasal obstruction/ facial pain/ smell (visual symmetry) scores, and the NOSE score.
· Significant improvement was observed in all outcome measures after 12 months, the SNOT-22 from 52.4±18.7 to 18.8±10.6
· The NOSE score from 72.8±16.4 to 20.2±11.6
· The peak inspiratory nasal airflow increased from 78.4±28.6 to 132.8±31.2 L/min
· Surgical success, overall, did not change after 12 months (82.1%).
In summary, in Iraqi people with treatment-resistant chronic sinusitis, high BMI, and EDSS are independent predictors of decreased likelihood of success.
Files
SJM-181- 2026-1-8.pdf
Files
(988.0 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:d2df3920a184660d8618c58c795668a4
|
988.0 kB | Preview Download |